Bolt Biotherapeutics faces Nasdaq delisting risk By Investing.com - Investing.com Australia
Bolt Biotherapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $5.31
+11% in 7d after detection
Post-detection moves
1h
—
1d
-2.3%
3d
+4.9%
7d
+11%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS